Advanced Coronary Intervention Inc.
This article was originally published in Start Up
Executive Summary
Surgical Devices; Restenosis. Advanced Coronary Intervention's guided selective atherectomy process combines real-time ultrasound sensors located on a catheter to guide a physician to a blockage. Radio frequency energy then ablates plaque without damaging arterial walls. Key to the system is the ability to modulate radio frequency energy in such a way that it removes thermocoagulation properties.
You may also be interested in...
Restenosis: Multi-Billion-Dollar Market Tempts Many
A variety of approaches are being used to combat the problem of restenosis following angioplasty. In addition to separate drug and device efforts, several companies are working on drug-device collaborations to prevent restenosis.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.